SRY and hepatocellular carcinoma: SRY (through its downstream factor SOX9) impairs the differentiation of liver progenitor cells into hepatocytes, contributing to chronic liver inflammation and fibrosis, thereby promoting hepatocellular carcinoma (HCC) progression (92).